Acute symptomatic seizure prevention with perampanel in moderate and severe traumatic brain injury: a retrospective comparison with levetiracetam.

Front Neurol · 2025 · PMC12571620 · PMID 41180532

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep = 0.05actually significant

Although the reduction in ASS did not reach statistical significance ( p = 0.05), the observed difference between the PER and LEV groups suggests a potential clinical benefit worthy of further study.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.